Materias dentro de su búsqueda.
Mostrando 24,141 - 24,160 Resultados de 24,879 Para Buscar '".eu"', tiempo de consulta: 0.29s Limitar resultados
  1. 24141
    “…STUDY DESIGN: This work aims to build a surveillance system, namely EpiMPX, that allows researchers and policymakers to monitor the impact of Monkeypox in Europe, with a special focus on the epidemic trends in the Italian regions, based on an open-access database containing information on the laboratory confirmed Monkeypox cases reported by EU/EEA countries and updated once a week. In addition, users will be provided open-access R codes to estimate key epidemiological parameters such as the reproduction number (updating the Serial Interval distribution when new estimates will be published) and produce real-time results on their devices. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Monkeypox: EpiMPX Surveillance System and Open Data with a Special Focus on European and Italian Epidemic
  2. 24142
    “…CLINICAL TRIALS REGISTRATION: NCT02798744, www.ClinicalTrials.gov; 2015‐001594‐40, www.EudraCT.ema.europa.eu; ISRCTN82062639, www.ISRCTN.org.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial
  3. 24143
    “…BACKGROUND: In the EU, approx. 16.5% of the 20–34-year-olds are Not in Education, Employment or Training (NEET). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The development of a health-promoting employment intervention with physical activity for young people Not in Education, Employment or Training (NEET): NEXT STEP—on the path to education and job
  4. 24144
    Publicado 2022
    “…The strategy of Health in All Policies (HiAP), promoted by the World Health Organization (WHO) and adopted by the European Union (EU) in 2006, reinforced the need to reduce inequalities and improve health and wellbeing as essential pillars for a sustainable economic development. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    9.G. Workshop: Health in all Policies: key driver for better health still awaiting of greater governing stewardship
  5. 24145
    Publicado 2022
    “…The presentations will be followed by a short round table discussion in order to highlight the role and strengths European health networks can bring to regions in order to improve cross-border healthcare (WHO RHN, Healthacross /Lower Austria, euPrevent, AEBR, EUREGHA). KEY MESSAGES: • Role and impact of health networking for cross-border health on a sub-national level. • Outlining the benefits and challenges for border regions to participate in health networks in order to strengthen cross-border health (also during Covid-19).…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    8.C. Workshop: Networking for life: How European regions develop/strengthen cross-border health
  6. 24146
    “…METHODS: Active users of the International Congenital Adrenal Hyperplasia & International Disorders of Sex Development (I-CAH/I-DSD) Registries (n=66), non-active users of I-CAH/I-DSD (n=35) and the EuRRECa e-Reporting Registry (n=10) were approached to complete an online survey. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PMON191 Current Management of Acute Adrenal Insufficiency Related Adverse Events in Children with Congenital Adrenal Hyperplasia- Results of an International Survey of Specialist Centres
  7. 24147
    por Hong, Yan, Zhang, Xiaoda
    Publicado 2022
    “…METHODS: A HL questionnaire with 68 questions is designed by combing the HLS-EU-Q47and the characteristics of Mongolians in China. 742 Mongolians aged 18 to 87 in Inner Mongolia of China answered the questionnaire. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Questionnaire and LGBM Model for Assessing Health Literacy levels of Mongolians in China
  8. 24148
    “…Registered 23 October 2015 https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-003045-26 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13550-022-00941-8.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Validation of dynamic [(18)F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [(15)O]H(2)O PET
  9. 24149
    por Fleury, Vincent
    Publicado 2022
    “…(Second order division in sectors as a prepattern for sensory organs in vertebrate development, 2021), Fleury and Abourachid (Eu Phys J E 45:31, 2022). Tensions in the sectors defined by the intersections of the said rings and rays create the actual face features. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Dynamics of early stages of nose morphogenesis
  10. 24150
    “…The Panel also performed a risk assessment for toxic elements present in sulfur dioxide–sulfites (E 220–228), based on data submitted by IBOs, and concluded that the maximum limits in the EU specifications for arsenic, lead and mercury should be lowered and a maximum limit for cadmium should be introduced.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Follow‐up of the re‐evaluation of sulfur dioxide (E 220), sodium sulfite (E 221), sodium bisulfite (E 222), sodium metabisulfite (E 223), potassium metabisulfite (E 224), calcium sulfite (E 226), calcium bisulfite (E 227) and potassium bisulfite (E 228)
  11. 24151
    “…The results of this study can be valuable to the psychoeducation of substance-addicted individuals and to current restriction/legalization debates, especially in the Western-EU.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates
  12. 24152
    “…Given Switzerland’s geographical proximity to European Union (EU) member states, the General Data Protection Regulation (GDPR) may impose additional obligations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Health data privacy through homomorphic encryption and distributed ledger computing: an ethical-legal qualitative expert assessment study
  13. 24153
    “…METHODS: A total of 11434 clinical isolates of Gram-negative bacilli were systematically collected from 16 EU countries, Israel and Turkey in 2020 and 2021. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    660. In vitro activity of cefiderocol against difficult-to-treat resistance European Gram-negative bacterial pathogens from the multi-national sentinel surveillance study, SENTRY in 2020 and 2021
  14. 24154
    “…ClinicalTrials.gov: NCT04902183, EU Clinical Trials Register EudraCT Number 2021-002184-22). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1153. Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study.
  15. 24155
    “…RESULTS: An independent Data Review Committee (DRC) provided an assessment of treatment response for 113 enrolled patients in the FURI study from 27 centers in US, UK and EU treated with ibrexafungerp for mucocutaneous or invasive fungal infections from 2016–2021. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    871. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)
  16. 24156
    “…TRIAL REGISTRATION (ADDITIONAL FILE 1): ClinicalTrials.gov (NCT03585270). EU Clinical Trial Register (EudraCT Number: 2018–000241-39). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
  17. 24157
    “…FUNDING: Innovative Medicines Initiative 2 Joint Undertaking, with support from the EU's Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
  18. 24158
    “…METHODS: All analyses were based on the EU-AIMS/AIMS-2-TRIALS multisite Longitudinal European Autism Project (LEAP) with participants with autism (n = 282) and typically developing (TD) controls (n = 221) between 6 and 30 years of age. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Patterns of connectome variability in autism across five functional activation tasks: findings from the LEAP project
  19. 24159
    “…METHODS AND FINDINGS: The predictive model introduced here is a comprehensive extension of the one underlying the pandemic preparedness tool CovidSim 2.0 (http://covidsim.eu/). The model is age and spatially stratified, incorporates a finite (but arbitrary) number of different viral variants, and incorporates different vaccine products. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines
  20. 24160
    “…Registered on June 2, 2016. EU Clinical Trials Register 2015-005438-24. Registered on May 6, 2016 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01163-3.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial
Herramientas de búsqueda: RSS